8L7 Stock Overview
Medhelp Care Aktiebolag (publ), a software-as-a-service company, operates a health platform for data-driven corporate health and supports in Sweden and Denmark.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Medhelp Care Aktiebolag (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.26 |
52 Week High | kr0.35 |
52 Week Low | kr0.22 |
Beta | 1.19 |
1 Month Change | 1.99% |
3 Month Change | -9.86% |
1 Year Change | -2.29% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -69.30% |
Recent News & Updates
Recent updates
Shareholder Returns
8L7 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | -3.0% | 0.4% | -1.9% |
1Y | -2.3% | -21.8% | 1.1% |
Return vs Industry: 8L7 exceeded the German Healthcare Services industry which returned -21.8% over the past year.
Return vs Market: 8L7 underperformed the German Market which returned 1.1% over the past year.
Price Volatility
8L7 volatility | |
---|---|
8L7 Average Weekly Movement | 5.3% |
Healthcare Services Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 9.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8L7 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8L7's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 42 | Tobias Ekros | www.medhelp.se |
Medhelp Care Aktiebolag (publ), a software-as-a-service company, operates a health platform for data-driven corporate health and supports in Sweden and Denmark. The company offers absence management, sickness absence statistics, health care advice, and rehabilitation support. Medhelp Care Aktiebolag (publ) was incorporated in 1999 and is based in Stockholm, Sweden.
Medhelp Care Aktiebolag (publ) Fundamentals Summary
8L7 fundamental statistics | |
---|---|
Market cap | €9.08m |
Earnings (TTM) | -€957.22k |
Revenue (TTM) | €7.79m |
1.2x
P/S Ratio-9.5x
P/E RatioIs 8L7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8L7 income statement (TTM) | |
---|---|
Revenue | kr90.39m |
Cost of Revenue | kr60.03m |
Gross Profit | kr30.36m |
Other Expenses | kr41.46m |
Earnings | -kr11.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.36 |
Gross Margin | 33.59% |
Net Profit Margin | -12.28% |
Debt/Equity Ratio | 19.2% |
How did 8L7 perform over the long term?
See historical performance and comparison